Portage Biotech Stock Probability of Future Stock Price Finishing Over 20.95
PRTG Stock | USD 3.98 0.06 1.49% |
Portage |
Portage Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Portage Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Portage Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Portage Biotech is way too risky over 90 days horizon | |
Portage Biotech appears to be risky and price may revert if volatility continues | |
Portage Biotech has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (75.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Portage Biotech currently holds about 21.18 M in cash with (14.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
Portage Biotech has a frail financial position based on the latest SEC disclosures | |
Roughly 30.0% of the company outstanding shares are owned by corporate insiders |
Portage Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Portage Stock often depends not only on the future outlook of the current and potential Portage Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Portage Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 20.3 M | |
Cash And Short Term Investments | 5 M |
Portage Biotech Technical Analysis
Portage Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Portage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Portage Biotech. In general, you should focus on analyzing Portage Stock price patterns and their correlations with different microeconomic environments and drivers.
Portage Biotech Predictive Forecast Models
Portage Biotech's time-series forecasting models is one of many Portage Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Portage Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Portage Biotech
Checking the ongoing alerts about Portage Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Portage Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Portage Biotech is way too risky over 90 days horizon | |
Portage Biotech appears to be risky and price may revert if volatility continues | |
Portage Biotech has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (75.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Portage Biotech currently holds about 21.18 M in cash with (14.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
Portage Biotech has a frail financial position based on the latest SEC disclosures | |
Roughly 30.0% of the company outstanding shares are owned by corporate insiders |
Check out Portage Biotech Backtesting, Portage Biotech Valuation, Portage Biotech Correlation, Portage Biotech Hype Analysis, Portage Biotech Volatility, Portage Biotech History as well as Portage Biotech Performance. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Portage Biotech. If investors know Portage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Portage Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Portage Biotech is measured differently than its book value, which is the value of Portage that is recorded on the company's balance sheet. Investors also form their own opinion of Portage Biotech's value that differs from its market value or its book value, called intrinsic value, which is Portage Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Portage Biotech's market value can be influenced by many factors that don't directly affect Portage Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Portage Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Portage Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Portage Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.